[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [ACTIVE] · [BUSINESS]

2 clusters · 2 sources · 10 days · First seen · Last updated

Institutional investment in Denali Therapeutics

Overview

Institutional investors have shown increased interest in Denali Therapeutics Inc. through significant stake acquisitions. Defilade Capital Management L.P. more than doubled its position in the first quarter, holding approximately 1,359,969 shares. Other major entities, including Norges Bank, Goldman Sachs Group, and T. Rowe Price, have also contributed to the firm’s institutional ownership.

Entities

Denali Therapeutics Inc. · ADMA Biologics Inc. · Glenmede Trust Co. NA · Revolve Wealth Partners LLC · Delta Air Lines, Inc.

Timeline

  1. 3 days ago

    [BUSINESS] 2 sources
    Institutional investors adjust holdings in Denali Therapeutics and Delta Air Lines

    Recent SEC filings show Sei Investments Co. taking a new position in Denali Therapeutics and Revolve Wealth Partners LLC investing $1.38 million in Delta Air Lines.

  2. 12 days ago

    [BUSINESS] 2 sources
    Institutional investors boost holdings in Denali Therapeutics and ADMA Biologics

    Defilade Capital and other funds expanded holdings in Denali Therapeutics, while Dimensional Fund Advisors increased its stake in ADMA Biologics, reflecting growing institutional interest in biotech stocks.

Sources

mommygearest.com · stocknews.com